LENVATINIB

LENVATINIB was reported 33515 times

LENVATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTHETIC CARDIAC VALVE OBSTRUCTION 9 0.7500
1 TRACHEAL FISTULA 39 0.2532
2 LIVER CARCINOMA RUPTURED 50 0.1984
3 THYROGLOBULIN DECREASED 9 0.1500
4 PRIMARY ADRENAL INSUFFICIENCY 40 0.1311
5 SILENT THYROIDITIS 18 0.1250
6 THYROGLOBULIN INCREASED 21 0.1235
7 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 96 0.1205
8 IMMUNE-MEDIATED ENCEPHALITIS 55 0.1040
9 OESOPHAGEAL FISTULA 33 0.1038
10 RENAL CELL CARCINOMA RECURRENT 12 0.0945
11 MEDICAL DEVICE SITE THROMBOSIS 9 0.0874
12 IMMUNE-MEDIATED HYPOTHYROIDISM 98 0.0869
13 UROGENITAL FISTULA 20 0.0844
14 IMMUNE-MEDIATED NEUROPATHY 13 0.0839
15 IMMUNE-MEDIATED PANCREATITIS 30 0.0787
16 ENDOMETRIAL CANCER RECURRENT 10 0.0763
17 PRIMARY HYPOTHYROIDISM 15 0.0708
18 TRACHEAL HAEMORRHAGE 24 0.0682
19 TUMOUR RUPTURE 38 0.0676
20 IMMUNE-MEDIATED THYROIDITIS 33 0.0668
21 TUMOUR HAEMORRHAGE 181 0.0634
22 PARALYSIS RECURRENT LARYNGEAL NERVE 9 0.0616
23 IMMUNE-MEDIATED CHOLANGITIS 22 0.0613
24 PROTEINURIA 1128 0.0593
25 HEPATIC ENCEPHALOPATHY 522 0.0559
26 IMMUNE-MEDIATED MYASTHENIA GRAVIS 18 0.0554
27 IMMUNE-MEDIATED LUNG DISEASE 96 0.0526
28 SICCA SYNDROME 10 0.0518
29 THROMBOPHLEBITIS MIGRANS 17 0.0500
30 IMMUNE-MEDIATED HEPATITIS 101 0.0494
31 HAEMOBILIA 20 0.0482
32 THYROIDITIS 141 0.0469
33 ADRENAL INSUFFICIENCY 559 0.0460
34 IMMUNE-MEDIATED RENAL DISORDER 19 0.0459
35 OESOPHAGEAL VARICES HAEMORRHAGE 97 0.0446
36 KL-6 INCREASED 10 0.0442
37 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1028 0.0441
38 AMMONIA INCREASED 224 0.0439
39 GALLBLADDER RUPTURE 20 0.0432
40 DUODENAL PERFORATION 42 0.0428
41 CHOLANGITIS ACUTE 32 0.0424
42 IMMUNE-MEDIATED ENTEROCOLITIS 153 0.0416
43 HEPATIC RUPTURE 9 0.0402
44 IMMUNE-MEDIATED DERMATITIS 39 0.0387
45 IMMUNE-MEDIATED MYOCARDITIS 62 0.0384
46 TRACHEO-OESOPHAGEAL FISTULA 24 0.0376
47 GASTROINTESTINAL PERFORATION 153 0.0368
48 SMALL INTESTINAL PERFORATION 69 0.0368
49 TUMOUR ASSOCIATED FEVER 15 0.0367
50 IMMUNE-MEDIATED NEPHRITIS 17 0.0362
51 HYPOTHYROIDISM 1158 0.0362
52 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 31 0.0353
53 FEMALE GENITAL TRACT FISTULA 60 0.0351
54 THYROID HORMONES DECREASED 28 0.0350
55 ARTERIAL HAEMORRHAGE 39 0.0341
56 IMMUNE-MEDIATED HYPOPHYSITIS 15 0.0333
57 RECTAL PERFORATION 17 0.0315
58 RHYTHM IDIOVENTRICULAR 10 0.0308
59 FULMINANT TYPE 1 DIABETES MELLITUS 30 0.0291
60 TUMOUR PAIN 38 0.0288
61 THYROID HORMONES INCREASED 30 0.0285
62 DIVERTICULITIS INTESTINAL PERFORATED 10 0.0280
63 OESOPHAGEAL PERFORATION 23 0.0276
64 ALPHA 1 FOETOPROTEIN INCREASED 19 0.0267
65 CANCER PAIN 68 0.0266
66 MALIGNANT NEOPLASM PROGRESSION 2570 0.0251
67 FISTULA OF SMALL INTESTINE 10 0.0239
68 PROTEIN URINE PRESENT 119 0.0238
69 IMMUNE-MEDIATED HEPATIC DISORDER 46 0.0236
70 CHOLECYSTITIS 276 0.0231
71 BILIARY OBSTRUCTION 29 0.0224
72 PERFORATION 18 0.0223
73 HEPATIC HAEMORRHAGE 19 0.0221
74 TUMOUR NECROSIS 23 0.0218
75 CHOLANGITIS 131 0.0211
76 CYTOKINE STORM 14 0.0204
77 ELECTROLYTE DEPLETION 10 0.0203
78 CHOLECYSTITIS ACUTE 111 0.0196
79 GASTRIC PERFORATION 53 0.0194
80 NEPHROTIC SYNDROME 133 0.0194
81 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 184 0.0193
82 BLOOD THYROID STIMULATING HORMONE INCREASED 173 0.0188
83 TYPE 1 DIABETES MELLITUS 113 0.0187
84 VASCULAR ACCESS COMPLICATION 15 0.0185
85 INTESTINAL PERFORATION 206 0.0183
86 ENCEPHALITIS AUTOIMMUNE 24 0.0183
87 THERAPY PARTIAL RESPONDER 284 0.0182
88 HYPERTENSION 3829 0.0181
89 HYPERTENSIVE URGENCY 10 0.0181
90 MALIGNANT PLEURAL EFFUSION 30 0.0178
91 INTRA-ABDOMINAL FLUID COLLECTION 31 0.0173
92 ORAL PAIN 385 0.0172
93 STOMATITIS 1023 0.0169
94 HYPERTENSIVE ENCEPHALOPATHY 10 0.0168
95 PORTAL VEIN THROMBOSIS 53 0.0164
96 THYROID FUNCTION TEST ABNORMAL 68 0.0164
97 PNEUMOTHORAX SPONTANEOUS 11 0.0162
98 ADRENAL DISORDER 31 0.0161
99 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 20 0.0161
100 ENTEROCOLITIS 92 0.0159
101 DYSPHONIA 918 0.0157
102 ACTIVITIES OF DAILY LIVING DECREASED 10 0.0156
103 MYOCARDITIS 178 0.0155
104 HYPOPITUITARISM 27 0.0155
105 AUTOIMMUNE COLITIS 10 0.0155
106 IMMUNE-MEDIATED ADVERSE REACTION 23 0.0150
107 GASTROINTESTINAL FISTULA 13 0.0148
108 INTERSTITIAL LUNG DISEASE 716 0.0148
109 AMYLASE INCREASED 54 0.0146
110 BLOOD PRESSURE INCREASED 2189 0.0143
111 POLYCYTHAEMIA 29 0.0140
112 TONGUE DISCOMFORT 59 0.0139
113 HYPERTHYROIDISM 201 0.0139
114 LARGE INTESTINE PERFORATION 95 0.0137
115 DECREASED APPETITE 3169 0.0136
116 OESOPHAGEAL HAEMORRHAGE 18 0.0136
117 PNEUMOTHORAX 215 0.0135
118 CHOLECYSTITIS INFECTIVE 37 0.0133
119 PROTEIN URINE 12 0.0133
120 TASTE DISORDER 264 0.0130
121 HYPOPHYSITIS 26 0.0129
122 RENAL CELL CARCINOMA 63 0.0129
123 HEPATIC FUNCTION ABNORMAL 475 0.0127
124 ASCITES 373 0.0127
125 BLOOD MAGNESIUM DECREASED 108 0.0125
126 CARDIAC DYSFUNCTION 46 0.0123
127 IMMUNE-MEDIATED MYOSITIS 34 0.0123
128 AORTIC DISSECTION 51 0.0123
129 ADRENOCORTICAL INSUFFICIENCY ACUTE 24 0.0123
130 CORTISOL DECREASED 14 0.0122
131 PNEUMATOSIS INTESTINALIS 34 0.0119
132 ENTEROVESICAL FISTULA 9 0.0119
133 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 19 0.0119
134 GASTRIC ULCER PERFORATION 15 0.0118
135 CHOLANGITIS SCLEROSING 24 0.0117
136 DEHYDRATION 1548 0.0116
137 PULMONARY CAVITATION 10 0.0115
138 TUMOUR LYSIS SYNDROME 101 0.0115
139 THYROTOXIC CRISIS 13 0.0114
140 LIVER ABSCESS 37 0.0114
141 ENTEROCUTANEOUS FISTULA 10 0.0113
142 HEPATIC LESION 49 0.0113
143 SECONDARY ADRENOCORTICAL INSUFFICIENCY 17 0.0113
144 HYPERKERATOSIS 62 0.0112
145 INFECTIOUS PLEURAL EFFUSION 17 0.0112
146 GALLBLADDER ENLARGEMENT 12 0.0111
147 BLOOD PRESSURE DIASTOLIC INCREASED 50 0.0108
148 NEPHRECTOMY 16 0.0108
149 THYROID DISORDER 166 0.0108
150 PALMAR ERYTHEMA 12 0.0104
151 HYPERAMMONAEMIA 52 0.0104
152 ENCEPHALITIS 71 0.0103
153 DIVERTICULAR PERFORATION 21 0.0102
154 NEPHRITIS 34 0.0102
155 HEPATOCELLULAR CARCINOMA 75 0.0099
156 BLOOD SODIUM DECREASED 185 0.0098
157 CEREBELLAR HAEMORRHAGE 14 0.0098
158 BLOOD PRESSURE FLUCTUATION 234 0.0097
159 GLOSSITIS 34 0.0096
160 VOCAL CORD PARALYSIS 17 0.0095
161 PLATELET COUNT DECREASED 1008 0.0094
162 HYPERTENSIVE EMERGENCY 11 0.0093
163 PRERENAL FAILURE 13 0.0092
164 BLOOD ELECTROLYTES DECREASED 13 0.0091
165 LUNG ABSCESS 19 0.0090
166 VARICES OESOPHAGEAL 27 0.0089
167 BLOOD BILIRUBIN INCREASED 240 0.0089
168 LYMPHANGIOSIS CARCINOMATOSA 9 0.0086
169 FISTULA 97 0.0086
170 COLITIS 318 0.0084
171 HEPATIC FAILURE 250 0.0083
172 METASTATIC RENAL CELL CARCINOMA 15 0.0082
173 PNEUMONITIS 222 0.0081
174 BLOOD THYROID STIMULATING HORMONE ABNORMAL 15 0.0081
175 PNEUMOPERITONEUM 15 0.0081
176 WOUND DEHISCENCE 27 0.0080
177 SMALL INTESTINAL HAEMORRHAGE 16 0.0079
178 RENAL HAEMORRHAGE 16 0.0079
179 CARDIAC VENTRICULAR THROMBOSIS 10 0.0077
180 LIPASE INCREASED 59 0.0077
181 RECTAL ULCER 9 0.0077
182 PROCALCITONIN INCREASED 9 0.0077
183 SINUS ARREST 12 0.0076
184 FAECES PALE 17 0.0076
185 METASTASES TO LUNG 88 0.0076
186 BLOOD ALBUMIN DECREASED 60 0.0076
187 INTRA-ABDOMINAL HAEMORRHAGE 18 0.0076
188 BLOOD CALCIUM DECREASED 84 0.0075
189 HYPERTENSIVE CRISIS 83 0.0075
190 IMMUNE THROMBOCYTOPENIA 34 0.0074
191 RENAL TUBULAR INJURY 9 0.0074
192 CARDIAC FAILURE ACUTE 49 0.0073
193 GLOSSODYNIA 164 0.0073
194 PRODUCT PACKAGING DIFFICULT TO OPEN 19 0.0073
195 CEREBRAL INFARCTION 176 0.0072
196 HYPOALBUMINAEMIA 56 0.0072
197 MUCOSAL INFLAMMATION 186 0.0071
198 JAUNDICE CHOLESTATIC 25 0.0071
199 GINGIVITIS 38 0.0070
200 DUODENAL ULCER HAEMORRHAGE 20 0.0070
201 EPISTAXIS 520 0.0069
202 PULMONARY TOXICITY 49 0.0069
203 GINGIVAL PAIN 55 0.0069
204 ANAL ABSCESS 37 0.0069
205 ERYTHEMA MULTIFORME 64 0.0069
206 ORAL DISCOMFORT 93 0.0067
207 MYOSITIS 60 0.0067
208 HAEMOPTYSIS 186 0.0067
209 FEEDING DISORDER 134 0.0066
210 DIARRHOEA 4243 0.0066
211 METASTASES TO SPINE 22 0.0065
212 DUODENAL ULCER 46 0.0065
213 HEPATORENAL SYNDROME 11 0.0065
214 RENAL IMPAIRMENT 543 0.0065
215 MOUTH HAEMORRHAGE 47 0.0064
216 ENDOMETRIAL CANCER 14 0.0064
217 HEPATIC PAIN 27 0.0063
218 ELECTROLYTE IMBALANCE 73 0.0063
219 NASAL ULCER 10 0.0063
220 PANCREATITIS 330 0.0062
221 MYASTHENIA GRAVIS 50 0.0062
222 BILIARY COLIC 18 0.0062
223 HYPONATRAEMIA 346 0.0061
224 HEPATITIS 157 0.0061
225 CEREBRAL HAEMORRHAGE 218 0.0061
226 HAEMATEMESIS 154 0.0061
227 SOFT TISSUE INFECTION 11 0.0060
228 BLOOD POTASSIUM ABNORMAL 16 0.0060
229 DRUG ERUPTION 106 0.0060
230 SKIN ULCER 152 0.0059
231 UPPER GASTROINTESTINAL HAEMORRHAGE 98 0.0058
232 ENTERITIS 37 0.0058
233 GASTRIC ULCER HAEMORRHAGE 32 0.0058
234 CARDIAC FAILURE 460 0.0057
235 ILEUS 71 0.0057
236 HYPOPHAGIA 146 0.0057
237 ODYNOPHAGIA 34 0.0057
238 NECROTISING FASCIITIS 20 0.0057
239 TUMOUR MARKER INCREASED 27 0.0056
240 DUODENITIS 17 0.0055
241 GASTROINTESTINAL NECROSIS 16 0.0055
242 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 41 0.0055
243 CACHEXIA 28 0.0054
244 GASTROINTESTINAL OBSTRUCTION 13 0.0054
245 TONGUE BLISTERING 12 0.0054
246 GALLBLADDER DISORDER 95 0.0053
247 SKIN TOXICITY 30 0.0053
248 WEIGHT DECREASED 1474 0.0053
249 NASAL DRYNESS 33 0.0053
250 GASTRIC HAEMORRHAGE 60 0.0052
251 FAILURE TO THRIVE 27 0.0052
252 BLOOD POTASSIUM DECREASED 156 0.0052
253 APHONIA 72 0.0052
254 EJECTION FRACTION DECREASED 80 0.0051
255 EARLY SATIETY 10 0.0051
256 PULMONARY HAEMORRHAGE 40 0.0051
257 LIVER DISORDER 226 0.0051
258 GASTROINTESTINAL OEDEMA 9 0.0051
259 ANAL FISTULA 27 0.0051
260 URINARY TRACT OBSTRUCTION 12 0.0051
261 EMBOLISM 42 0.0051
262 PHYSICAL DECONDITIONING 13 0.0050
263 BILE DUCT STONE 16 0.0050
264 PYODERMA GANGRENOSUM 18 0.0050
265 FLUID INTAKE REDUCED 25 0.0050
266 PLEURAL EFFUSION 301 0.0049
267 DECREASED ACTIVITY 53 0.0049
268 HYPERCALCAEMIA 60 0.0049
269 STRESS CARDIOMYOPATHY 28 0.0048
270 FAECES SOFT 35 0.0048
271 GASTROINTESTINAL TOXICITY 23 0.0048
272 HYPOPROTEINAEMIA 9 0.0047
273 RENAL FUNCTION TEST ABNORMAL 22 0.0047
274 ALTERED STATE OF CONSCIOUSNESS 102 0.0047
275 DRY MOUTH 382 0.0047
276 ABDOMINAL INFECTION 12 0.0047
277 APPETITE DISORDER 31 0.0047
278 DRUG TITRATION ERROR 12 0.0046
279 INTERNAL HAEMORRHAGE 53 0.0046
280 IMPAIRED HEALING 152 0.0046
281 BLOOD THYROID STIMULATING HORMONE DECREASED 21 0.0046
282 CYTOKINE RELEASE SYNDROME 92 0.0046
283 LEUKOENCEPHALOPATHY 17 0.0046
284 BLOOD CALCIUM INCREASED 40 0.0046
285 BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0045
286 HYPERBILIRUBINAEMIA 47 0.0045
287 BLOOD CREATININE INCREASED 296 0.0045
288 PATHOLOGICAL FRACTURE 23 0.0045
289 GINGIVAL SWELLING 20 0.0045
290 OSTEONECROSIS OF JAW 112 0.0045
291 ASPARTATE AMINOTRANSFERASE INCREASED 239 0.0045
292 MENINGITIS 30 0.0045
293 GASTROINTESTINAL MOTILITY DISORDER 24 0.0045
294 ACUTE CORONARY SYNDROME 37 0.0045
295 CARDIOMYOPATHY 66 0.0045
296 ABSCESS LIMB 19 0.0045
297 LARGE INTESTINAL HAEMORRHAGE 10 0.0045
298 DIVERTICULUM INTESTINAL HAEMORRHAGIC 10 0.0044
299 BLOOD POTASSIUM INCREASED 72 0.0044
300 NON-CARDIAC CHEST PAIN 14 0.0044
301 ASTHENIA 1661 0.0044
302 DISSEMINATED INTRAVASCULAR COAGULATION 62 0.0044
303 FATIGUE 3425 0.0044
304 PYELONEPHRITIS 38 0.0044
305 RETINAL ARTERY OCCLUSION 11 0.0043
306 RED BLOOD CELL COUNT INCREASED 12 0.0043
307 VOMITING 2044 0.0043
308 IMPAIRED SELF-CARE 9 0.0043
309 MUSCULOSKELETAL CHEST PAIN 67 0.0043
310 HAEMORRHOIDAL HAEMORRHAGE 21 0.0043
311 MALNUTRITION 48 0.0043
312 CONSTIPATION 933 0.0043
313 METASTASES TO BONE 70 0.0043
314 PROTEIN TOTAL DECREASED 16 0.0042
315 PEMPHIGOID 32 0.0042
316 HYPOCALCAEMIA 80 0.0042
317 BLOOD PRESSURE ABNORMAL 84 0.0042
318 PNEUMONIA ASPIRATION 105 0.0042
319 PULMONARY EMBOLISM 399 0.0042
320 PANCREATITIS ACUTE 94 0.0042
321 C-REACTIVE PROTEIN INCREASED 152 0.0042
322 RETINAL VEIN OCCLUSION 12 0.0042
323 CARBOHYDRATE ANTIGEN 125 INCREASED 14 0.0041
324 JAUNDICE 110 0.0041
325 PROCTALGIA 26 0.0040
326 GINGIVAL BLEEDING 55 0.0040
327 THROMBOTIC MICROANGIOPATHY 39 0.0040
328 ACUTE MYOCARDIAL INFARCTION 118 0.0040
329 METABOLIC ENCEPHALOPATHY 12 0.0040
330 GASTROENTERITIS 58 0.0040
331 TOXIC ENCEPHALOPATHY 20 0.0039
332 ENCEPHALOPATHY 96 0.0039
333 HICCUPS 32 0.0039
334 BLOOD URINE PRESENT 74 0.0039
335 AUTOIMMUNE HEPATITIS 27 0.0039
336 ALANINE AMINOTRANSFERASE INCREASED 238 0.0039
337 TONGUE ULCERATION 13 0.0038
338 MOUTH ULCERATION 81 0.0038
339 HAEMORRHAGIC STROKE 30 0.0038
340 FLANK PAIN 36 0.0038
341 BLOOD CREATININE DECREASED 12 0.0038
342 BLOOD PHOSPHORUS DECREASED 14 0.0038
343 PYREXIA 1325 0.0038
344 ABDOMINAL PAIN 884 0.0038
345 SUDDEN DEATH 40 0.0038
346 LIVER FUNCTION TEST INCREASED 81 0.0038
347 HYPERTRANSAMINASAEMIA 26 0.0037
348 PAINFUL RESPIRATION 9 0.0037
349 GUILLAIN-BARRE SYNDROME 18 0.0037
350 MYELOSUPPRESSION 134 0.0037
351 BLISTER 208 0.0037
352 LIP BLISTER 10 0.0037
353 DERMATITIS ACNEIFORM 22 0.0036
354 HEPATIC ENZYME ABNORMAL 18 0.0036
355 PNEUMOCYSTIS JIROVECII PNEUMONIA 36 0.0036
356 GENERALISED OEDEMA 44 0.0036
357 OXYGEN SATURATION ABNORMAL 10 0.0035
358 ACUTE KIDNEY INJURY 539 0.0035
359 ABDOMINAL HERNIA 16 0.0035
360 HAEMOGLOBIN INCREASED 16 0.0035
361 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
362 LIP PAIN 10 0.0035
363 NEOPLASM 40 0.0035
364 BONE CANCER 15 0.0034
365 URINE OUTPUT DECREASED 30 0.0034
366 PERIPHERAL SENSORY NEUROPATHY 20 0.0034
367 HAEMATURIA 116 0.0034
368 GINGIVAL DISORDER 13 0.0034
369 PERITONITIS 70 0.0034
370 FIBRIN D DIMER INCREASED 12 0.0034
371 HAEMORRHAGE INTRACRANIAL 50 0.0033
372 BLOOD SODIUM INCREASED 9 0.0033
373 LYMPHOEDEMA 23 0.0033
374 LARGE INTESTINAL ULCER 9 0.0033
375 GASTRIC ULCER 63 0.0033
376 HYPOXIA 116 0.0033
377 RENAL DISORDER 153 0.0033
378 FOOD INTOLERANCE 12 0.0033
379 METASTASES TO CENTRAL NERVOUS SYSTEM 42 0.0033
380 AGEUSIA 81 0.0032
381 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 33 0.0032
382 OEDEMA 174 0.0032
383 NAUSEA 2531 0.0032
384 HYPERAESTHESIA 26 0.0032
385 HEPATIC ENZYME INCREASED 215 0.0032
386 POLYMYALGIA RHEUMATICA 10 0.0031
387 EATING DISORDER 67 0.0031
388 OESOPHAGITIS 34 0.0031
389 APPENDICITIS 29 0.0031
390 MALAISE 1358 0.0031
391 THROMBOCYTOPENIA 342 0.0031
392 NAIL DISCOLOURATION 12 0.0030
393 GASTROINTESTINAL HAEMORRHAGE 255 0.0030
394 SUBARACHNOID HAEMORRHAGE 31 0.0030
395 SKIN DISORDER 101 0.0030
396 METASTASES TO LIVER 53 0.0030
397 PERFORMANCE STATUS DECREASED 14 0.0030
398 MELAENA 66 0.0030
399 TRANSIENT ISCHAEMIC ATTACK 101 0.0030
400 ABDOMINAL PAIN UPPER 616 0.0030
401 YELLOW SKIN 14 0.0030
402 DECUBITUS ULCER 24 0.0029
403 HYPOMAGNESAEMIA 41 0.0029
404 PNEUMONIA BACTERIAL 27 0.0029
405 INCOHERENT 19 0.0029
406 HYPERSOMNIA 84 0.0029
407 BRAIN OEDEMA 37 0.0029
408 ANGINA UNSTABLE 19 0.0029
409 BLOOD CREATININE ABNORMAL 10 0.0029
410 BLOOD PRESSURE DECREASED 192 0.0029
411 NEUTROPHIL COUNT DECREASED 117 0.0029
412 BLOOD UREA INCREASED 48 0.0029
413 SENSITIVE SKIN 21 0.0028
414 POLYARTHRITIS 15 0.0028
415 URINARY TRACT INFECTION 485 0.0028
416 STEVENS-JOHNSON SYNDROME 63 0.0028
417 EPIGASTRIC DISCOMFORT 11 0.0028
418 ORAL INFECTION 11 0.0028
419 SKIN EROSION 9 0.0028
420 LOOSE TOOTH 9 0.0028
421 MYALGIA 474 0.0028
422 INTESTINAL OBSTRUCTION 105 0.0028
423 DRUG-INDUCED LIVER INJURY 87 0.0028
424 BONE LESION 10 0.0028
425 TROPONIN INCREASED 21 0.0028
426 DRY THROAT 28 0.0028
427 OROPHARYNGEAL PAIN 255 0.0028
428 HYPOTENSION 550 0.0027
429 CORONAVIRUS INFECTION 18 0.0027
430 ABDOMINAL ABSCESS 12 0.0027
431 APHTHOUS ULCER 21 0.0027
432 WOUND HAEMORRHAGE 10 0.0027
433 RASH VESICULAR 13 0.0027
434 DYSPHAGIA 255 0.0027
435 COLITIS ISCHAEMIC 18 0.0027
436 POSTOPERATIVE WOUND INFECTION 18 0.0027
437 CANDIDA INFECTION 45 0.0027
438 METASTASIS 19 0.0027
439 SEPSIS 296 0.0027
440 TRANSAMINASES INCREASED 59 0.0027
441 RENAL FAILURE 352 0.0026
442 HEPATOTOXICITY 59 0.0026
443 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
444 CONFUSIONAL STATE 423 0.0026
445 ANAEMIA 499 0.0026
446 LEFT VENTRICULAR FAILURE 9 0.0026
447 MOUTH SWELLING 15 0.0026
448 MUSCLE FATIGUE 11 0.0026
449 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
450 FAECES DISCOLOURED 56 0.0026
451 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
452 EMBOLIC STROKE 9 0.0026
453 GASTROINTESTINAL INFLAMMATION 20 0.0026
454 HYDRONEPHROSIS 19 0.0025
455 GAIT INABILITY 84 0.0025
456 HYPOKALAEMIA 116 0.0025
457 GOUT 45 0.0025
458 HYPOVOLAEMIC SHOCK 12 0.0025
459 RASH 1089 0.0025
460 UROSEPSIS 23 0.0025
461 TOOTHACHE 45 0.0025
462 BLOOD CREATINE INCREASED 11 0.0025
463 CARDIOTOXICITY 22 0.0025
464 ORAL DISORDER 18 0.0025
465 GASTROINTESTINAL INFECTION 22 0.0025
466 RENAL PAIN 26 0.0025
467 HYPERKALAEMIA 86 0.0024
468 HAEMATOCHEZIA 135 0.0024
469 CARDIOGENIC SHOCK 35 0.0024
470 PANCREATIC DISORDER 12 0.0024
471 COMPRESSION FRACTURE 13 0.0024
472 PULMONARY MASS 36 0.0024
473 ISCHAEMIC STROKE 43 0.0024
474 FEELING COLD 67 0.0024
475 GASTRITIS 63 0.0024
476 FAECALOMA 13 0.0024
477 LETHARGY 136 0.0024
478 ELECTROCARDIOGRAM QT PROLONGED 85 0.0024
479 FLATULENCE 134 0.0024
480 BACTERAEMIA 28 0.0024
481 PERIPHERAL SWELLING 363 0.0024
482 OESOPHAGEAL ULCER 9 0.0023
483 NECROSIS 13 0.0023
484 CYSTITIS 74 0.0023
485 SKIN INFECTION 26 0.0023
486 CARDIAC TAMPONADE 11 0.0023
487 HAEMORRHOIDS 45 0.0023
488 HEART RATE DECREASED 81 0.0023
489 BONE PAIN 135 0.0023
490 NODULE 30 0.0023
491 BRAIN FOG 36 0.0023
492 MUSCULOSKELETAL PAIN 120 0.0023
493 BRAIN NEOPLASM 21 0.0023
494 SMALL INTESTINAL OBSTRUCTION 28 0.0023
495 BLOOD URIC ACID INCREASED 13 0.0022
496 ARTHRALGIA 933 0.0022
497 OEDEMA PERIPHERAL 273 0.0022
498 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
499 BOWEL MOVEMENT IRREGULARITY 17 0.0022
500 ULCER HAEMORRHAGE 15 0.0022
501 TONGUE DISORDER 16 0.0022
502 RECURRENT CANCER 9 0.0022
503 ABDOMINAL DISCOMFORT 365 0.0022
504 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
505 PNEUMONIA 702 0.0022
506 LOCALISED OEDEMA 10 0.0022
507 CEREBROVASCULAR ACCIDENT 366 0.0022
508 SEPTIC SHOCK 94 0.0022
509 BACK PAIN 499 0.0021
510 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
511 BLOOD ALKALINE PHOSPHATASE INCREASED 53 0.0021
512 TRISMUS 11 0.0021
513 DIVERTICULITIS 59 0.0021
514 DIABETIC KETOACIDOSIS 51 0.0021
515 PERICARDIAL EFFUSION 49 0.0021
516 ANAL INCONTINENCE 19 0.0021
517 RETCHING 45 0.0021
518 FEBRILE NEUTROPENIA 140 0.0021
519 INCONTINENCE 22 0.0021
520 TUBULOINTERSTITIAL NEPHRITIS 39 0.0021
521 NECK PAIN 116 0.0021
522 DELIRIUM 72 0.0021
523 ULCER 33 0.0021
524 NEOPLASM PROGRESSION 72 0.0021
525 ATELECTASIS 20 0.0021
526 ANORECTAL DISCOMFORT 11 0.0021
527 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
528 ABDOMINAL DISTENSION 215 0.0021
529 ANAL FISSURE 11 0.0020
530 HYPERTRIGLYCERIDAEMIA 12 0.0020
531 RASH PRURITIC 111 0.0020
532 LIVER INJURY 50 0.0020
533 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
534 PLEURISY 12 0.0020
535 RENAL CANCER 96 0.0020
536 DYSGEUSIA 149 0.0020
537 MENINGITIS ASEPTIC 9 0.0020
538 PULMONARY OEDEMA 89 0.0020
539 CHOLELITHIASIS 65 0.0020
540 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
541 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
542 HAEMORRHAGE 206 0.0020
543 DEEP VEIN THROMBOSIS 128 0.0020
544 HEADACHE 1228 0.0020
545 FEMORAL NECK FRACTURE 10 0.0019
546 CEREBRAL ISCHAEMIA 10 0.0019
547 ABSCESS 31 0.0019
548 GASTROENTERITIS VIRAL 35 0.0019
549 GROIN PAIN 17 0.0019
550 TENDERNESS 20 0.0019
551 FACIAL PAIN 17 0.0019
552 NEUROPATHY PERIPHERAL 181 0.0019
553 COLITIS MICROSCOPIC 9 0.0019
554 POST PROCEDURAL HAEMORRHAGE 22 0.0019
555 RED BLOOD CELL COUNT DECREASED 54 0.0019
556 MULTIPLE ORGAN DYSFUNCTION SYNDROME 53 0.0019
557 EYELID PTOSIS 19 0.0019
558 THROMBOSIS 150 0.0019
559 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
560 CHEILITIS 10 0.0018
561 INCORRECT DOSAGE ADMINISTERED 9 0.0018
562 RECTAL HAEMORRHAGE 79 0.0018
563 SEASONAL ALLERGY 26 0.0018
564 RENAL TUBULAR NECROSIS 18 0.0018
565 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
566 WOUND INFECTION 20 0.0018
567 INTESTINAL ISCHAEMIA 10 0.0018
568 HEPATIC CYTOLYSIS 23 0.0018
569 MENTAL STATUS CHANGES 50 0.0018
570 DISORIENTATION 71 0.0018
571 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 86 0.0018
572 GENERAL PHYSICAL HEALTH DETERIORATION 206 0.0018
573 BLOOD TEST ABNORMAL 25 0.0018
574 VAGINAL HAEMORRHAGE 77 0.0018
575 MUSCULAR WEAKNESS 201 0.0018
576 DYSPEPSIA 173 0.0018
577 ERUCTATION 34 0.0018
578 ATRIAL FIBRILLATION 171 0.0018
579 TOOTH DISORDER 39 0.0018
580 COUGH 490 0.0017
581 THYROID CANCER 21 0.0017
582 CHEST PAIN 323 0.0017
583 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
584 PAIN IN EXTREMITY 513 0.0017
585 SKIN ATROPHY 10 0.0017
586 MUSCLE STRAIN 15 0.0017
587 SEIZURE 200 0.0017
588 PAIN IN JAW 49 0.0017
589 CHROMATURIA 39 0.0017
590 WHITE BLOOD CELL COUNT DECREASED 185 0.0017
591 PURPURA 15 0.0017
592 MYOCARDIAL INFARCTION 295 0.0017
593 HEART RATE INCREASED 167 0.0017
594 BLOOD IRON DECREASED 20 0.0017
595 THIRST 30 0.0017
596 IMMUNE SYSTEM DISORDER 22 0.0017
597 WALKING AID USER 11 0.0017
598 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
599 CARDIAC FAILURE CONGESTIVE 133 0.0017
600 SKIN EXFOLIATION 138 0.0016
601 VASCULITIS 19 0.0016
602 HYPOPHOSPHATAEMIA 12 0.0016
603 LARYNGEAL OEDEMA 10 0.0016
604 APHASIA 49 0.0016
605 HAEMOGLOBIN DECREASED 166 0.0016
606 DRY SKIN 215 0.0016
607 LUNG INFECTION 25 0.0016
608 ANGINA PECTORIS 46 0.0016
609 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
610 SHOCK HAEMORRHAGIC 13 0.0016
611 TOOTH INFECTION 21 0.0016
612 PRODUCTIVE COUGH 76 0.0016
613 HYPERGLYCAEMIA 58 0.0016
614 KIDNEY INFECTION 31 0.0016
615 SPINAL COMPRESSION FRACTURE 13 0.0016
616 TOOTH ABSCESS 16 0.0016
617 HAEMOGLOBIN ABNORMAL 10 0.0016
618 OROPHARYNGEAL DISCOMFORT 14 0.0015
619 OSTEOMYELITIS 28 0.0015
620 HEPATIC CIRRHOSIS 29 0.0015
621 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
622 PHARYNGEAL SWELLING 15 0.0015
623 DERMATITIS 32 0.0015
624 THERAPY CHANGE 15 0.0015
625 SHOCK 35 0.0015
626 BLOOD GLUCOSE DECREASED 73 0.0015
627 DERMATITIS BULLOUS 11 0.0015
628 DYSPNOEA 860 0.0015
629 PULMONARY CONGESTION 20 0.0015
630 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
631 INFECTION 219 0.0015
632 LIVER FUNCTION TEST ABNORMAL 44 0.0015
633 MUSCULOSKELETAL DISCOMFORT 26 0.0015
634 MUSCLE ATROPHY 19 0.0015
635 DEVICE RELATED INFECTION 23 0.0015
636 RASH MACULO-PAPULAR 33 0.0015
637 NEURALGIA 36 0.0015
638 ASPHYXIA 12 0.0015
639 PIGMENTATION DISORDER 9 0.0015
640 FLUID RETENTION 74 0.0015
641 TEMPERATURE INTOLERANCE 15 0.0015
642 HERNIA 28 0.0014
643 DENTAL CARIES 16 0.0014
644 EAR PAIN 28 0.0014
645 URINARY RETENTION 48 0.0014
646 ATRIOVENTRICULAR BLOCK 11 0.0014
647 LYMPHOCYTE COUNT DECREASED 25 0.0014
648 ACUTE RESPIRATORY FAILURE 27 0.0014
649 NOCTURIA 17 0.0014
650 WOUND 39 0.0014
651 HEPATITIS ACUTE 9 0.0014
652 CHILLS 162 0.0014
653 UTERINE CANCER 11 0.0014
654 CYST 17 0.0014
655 ASPIRATION 15 0.0014
656 CELLULITIS 69 0.0014
657 GASTROINTESTINAL PAIN 15 0.0014
658 DISEASE PROGRESSION 161 0.0014
659 MUSCLE SPASMS 249 0.0014
660 SOMNOLENCE 271 0.0013
661 WEIGHT FLUCTUATION 14 0.0013
662 NEPHROPATHY TOXIC 15 0.0013
663 KETOACIDOSIS 10 0.0013
664 METASTASES TO LYMPH NODES 9 0.0013
665 FULL BLOOD COUNT ABNORMAL 14 0.0013
666 EOSINOPHIL COUNT INCREASED 11 0.0013
667 POLLAKIURIA 55 0.0013
668 SWOLLEN TONGUE 41 0.0013
669 DIZZINESS 653 0.0013
670 ABDOMINAL PAIN LOWER 33 0.0013
671 DYSURIA 48 0.0013
672 PLATELET COUNT INCREASED 17 0.0013
673 LYMPHADENOPATHY 46 0.0013
674 LIMB DISCOMFORT 40 0.0013
675 ORAL CANDIDIASIS 17 0.0013
676 TOXIC SKIN ERUPTION 13 0.0013
677 FACIAL PARALYSIS 11 0.0013
678 HYPOTHERMIA 13 0.0013
679 DIARRHOEA HAEMORRHAGIC 12 0.0013
680 SPINAL PAIN 15 0.0013
681 MOTOR DYSFUNCTION 13 0.0013
682 SLUGGISHNESS 13 0.0013
683 MYOPATHY 11 0.0013
684 PAIN 781 0.0013
685 NEUTROPHIL COUNT INCREASED 13 0.0013
686 FRACTURE 24 0.0013
687 RETINAL HAEMORRHAGE 9 0.0013
688 RESPIRATORY FAILURE 91 0.0012
689 SPEECH DISORDER 65 0.0012
690 BACTERIAL INFECTION 23 0.0012
691 SKIN FISSURES 24 0.0012
692 GAIT DISTURBANCE 234 0.0012
693 JOINT STIFFNESS 32 0.0012
694 PANCYTOPENIA 68 0.0012
695 MASS 17 0.0012
696 HAEMATOCRIT DECREASED 24 0.0012
697 SECOND PRIMARY MALIGNANCY 10 0.0012
698 DEATH 1035 0.0012
699 COGNITIVE DISORDER 56 0.0012
700 CHOLESTASIS 23 0.0012
701 INSOMNIA 317 0.0012
702 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
703 SUBDURAL HAEMATOMA 17 0.0012
704 BLOOD COUNT ABNORMAL 18 0.0012
705 LOSS OF CONSCIOUSNESS 152 0.0012
706 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
707 VITAMIN D DECREASED 10 0.0012
708 EAR DISCOMFORT 12 0.0012
709 HAEMATOTOXICITY 11 0.0012
710 PELVIC FRACTURE 9 0.0012
711 DIABETES MELLITUS 88 0.0012
712 RHABDOMYOLYSIS 48 0.0011
713 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
714 ORTHOSTATIC HYPOTENSION 20 0.0011
715 BALANCE DISORDER 99 0.0011
716 CYTOPENIA 14 0.0011
717 NAIL DISORDER 10 0.0011
718 GASTROOESOPHAGEAL REFLUX DISEASE 92 0.0011
719 FURUNCLE 9 0.0011
720 DIZZINESS POSTURAL 11 0.0011
721 DYSSTASIA 33 0.0011
722 ATRIAL FLUTTER 9 0.0011
723 HYPOAESTHESIA ORAL 17 0.0011
724 ORAL HERPES 22 0.0011
725 RIB FRACTURE 23 0.0011
726 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
727 HYPOKINESIA 16 0.0011
728 ARTHRITIS 86 0.0011
729 PERITONITIS BACTERIAL 11 0.0011
730 DYSPNOEA EXERTIONAL 41 0.0011
731 VAGINAL DISCHARGE 11 0.0011
732 JOINT SWELLING 131 0.0011
733 NERVE COMPRESSION 10 0.0011
734 GASTROINTESTINAL DISORDER 97 0.0011
735 HEMIPLEGIA 9 0.0011
736 ACNE 82 0.0011
737 URINARY INCONTINENCE 32 0.0011
738 BODY TEMPERATURE INCREASED 22 0.0011
739 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
740 LOCALISED INFECTION 26 0.0011
741 BEDRIDDEN 14 0.0011
742 SKIN REACTION 15 0.0011
743 ARTERIOSCLEROSIS 10 0.0011
744 VENTRICULAR EXTRASYSTOLES 11 0.0011
745 NIGHT SWEATS 34 0.0011
746 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
747 PRURITUS 401 0.0010
748 FULL BLOOD COUNT DECREASED 21 0.0010
749 PAIN OF SKIN 28 0.0010
750 DIPLOPIA 27 0.0010
751 SKIN SWELLING 9 0.0010
752 SINUS CONGESTION 14 0.0010
753 SINUS BRADYCARDIA 10 0.0010
754 MENTAL IMPAIRMENT 25 0.0010
755 CONTUSION 99 0.0010
756 CYTOMEGALOVIRUS INFECTION 17 0.0010
757 PRODUCT PRESCRIBING ISSUE 22 0.0010
758 INFLAMMATION 52 0.0010
759 BLOOD GLUCOSE FLUCTUATION 11 0.0010
760 RASH MACULAR 35 0.0010
761 AMNESIA 65 0.0010
762 PRODUCT USE IN UNAPPROVED INDICATION 247 0.0010
763 FALL 331 0.0010
764 PULMONARY FIBROSIS 19 0.0010
765 HYPOGLYCAEMIA 48 0.0010
766 SINUS TACHYCARDIA 14 0.0010
767 EPILEPSY 30 0.0010
768 INITIAL INSOMNIA 10 0.0010
769 BLOOD GLUCOSE ABNORMAL 18 0.0010
770 HEART RATE IRREGULAR 22 0.0010
771 PARAESTHESIA ORAL 14 0.0010
772 QUALITY OF LIFE DECREASED 13 0.0010
773 UNRESPONSIVE TO STIMULI 25 0.0010
774 MOVEMENT DISORDER 31 0.0010
775 SECRETION DISCHARGE 12 0.0010
776 DYSARTHRIA 36 0.0010
777 SKIN LESION 26 0.0009
778 SYNCOPE 94 0.0009
779 HYPERCHOLESTEROLAEMIA 9 0.0009
780 HYPERLIPIDAEMIA 11 0.0009
781 SKIN LACERATION 10 0.0009
782 THERAPY CESSATION 47 0.0009
783 THROAT IRRITATION 41 0.0009
784 SARS-COV-2 TEST POSITIVE 12 0.0009
785 PARALYSIS 13 0.0009
786 TOOTH FRACTURE 10 0.0009
787 BLADDER DISORDER 9 0.0009
788 HERPES ZOSTER 52 0.0009
789 NEUTROPENIA 123 0.0009
790 CARDIAC ARREST 74 0.0009
791 HAEMATOMA 23 0.0009
792 TREMOR 147 0.0009
793 HEMIPARESIS 15 0.0009
794 STATUS EPILEPTICUS 10 0.0009
795 HAIR COLOUR CHANGES 11 0.0009
796 POOR QUALITY SLEEP 19 0.0009
797 MYOCARDIAL ISCHAEMIA 10 0.0009
798 BONE DISORDER 16 0.0009
799 GASTRIC DISORDER 30 0.0009
800 BRADYCARDIA 46 0.0009
801 PRODUCT USE ISSUE 162 0.0009
802 SINUS DISORDER 17 0.0009
803 RHINORRHOEA 55 0.0009
804 HALLUCINATION 64 0.0008
805 HYPOAESTHESIA 127 0.0008
806 LYMPHOPENIA 12 0.0008
807 ACCIDENTAL OVERDOSE 31 0.0008
808 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
809 ARRHYTHMIA 40 0.0008
810 CARDIAC DISORDER 79 0.0008
811 SWELLING 79 0.0008
812 DELUSION 13 0.0008
813 BLOOD CHOLESTEROL INCREASED 39 0.0008
814 OXYGEN SATURATION DECREASED 47 0.0008
815 RESPIRATORY DISTRESS 23 0.0008
816 CORONARY ARTERY DISEASE 25 0.0008
817 LEUKOPENIA 41 0.0008
818 MEMORY IMPAIRMENT 112 0.0008
819 FREQUENT BOWEL MOVEMENTS 22 0.0008
820 THERAPY INTERRUPTED 58 0.0008
821 MUSCLE TIGHTNESS 13 0.0008
822 PERIPHERAL COLDNESS 11 0.0008
823 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
824 DERMATITIS ALLERGIC 10 0.0008
825 CHEST DISCOMFORT 81 0.0008
826 MICTURITION URGENCY 9 0.0008
827 COAGULOPATHY 13 0.0008
828 SLEEP DISORDER 55 0.0008
829 ERYTHEMA 160 0.0008
830 RASH ERYTHEMATOUS 37 0.0008
831 LIMB INJURY 21 0.0008
832 CARDIO-RESPIRATORY ARREST 32 0.0008
833 DRUG INTERACTION 121 0.0008
834 COVID-19 PNEUMONIA 9 0.0008
835 MYELODYSPLASTIC SYNDROME 11 0.0008
836 TACHYCARDIA 67 0.0008
837 NEPHROLITHIASIS 34 0.0007
838 SKIN DISCOLOURATION 34 0.0007
839 BACK DISORDER 12 0.0007
840 UVEITIS 10 0.0007
841 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
842 MUSCULOSKELETAL STIFFNESS 64 0.0007
843 CATARACT 43 0.0007
844 BLOOD GLUCOSE INCREASED 136 0.0007
845 NASOPHARYNGITIS 133 0.0007
846 LEUKOCYTOSIS 13 0.0007
847 FEELING ABNORMAL 172 0.0007
848 LUNG DISORDER 35 0.0007
849 RASH PAPULAR 16 0.0007
850 SWELLING FACE 46 0.0007
851 CIRCULATORY COLLAPSE 12 0.0007
852 DRUG INTOLERANCE 68 0.0007
853 ALOPECIA 137 0.0007
854 RASH GENERALISED 18 0.0007
855 MIGRAINE 66 0.0007
856 RESPIRATORY TRACT INFECTION 18 0.0007
857 FUNGAL INFECTION 23 0.0007
858 SCIATICA 11 0.0007
859 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
860 NASAL CONGESTION 40 0.0007
861 COLON CANCER 10 0.0007
862 BURNING SENSATION 47 0.0007
863 PALLOR 18 0.0007
864 IMPAIRED GASTRIC EMPTYING 9 0.0007
865 ACUTE HEPATIC FAILURE 9 0.0007
866 JOINT INJURY 14 0.0007
867 TINNITUS 30 0.0007
868 FACE OEDEMA 11 0.0007
869 VISUAL IMPAIRMENT 80 0.0006
870 LABORATORY TEST ABNORMAL 19 0.0006
871 ILLNESS 66 0.0006
872 BONE MARROW FAILURE 13 0.0006
873 RENAL INJURY 19 0.0006
874 SNEEZING 14 0.0006
875 HEAD DISCOMFORT 11 0.0006
876 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
877 COVID-19 109 0.0006
878 VISION BLURRED 85 0.0006
879 INFUSION RELATED REACTION 41 0.0006
880 SINUSITIS 63 0.0006
881 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
882 OFF LABEL USE 537 0.0006
883 VERTIGO 37 0.0006
884 VENTRICULAR TACHYCARDIA 10 0.0006
885 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
886 HEAD INJURY 19 0.0006
887 SPINAL FRACTURE 12 0.0006
888 MOBILITY DECREASED 43 0.0006
889 DISTURBANCE IN ATTENTION 32 0.0006
890 PALPITATIONS 67 0.0006
891 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
892 COLD SWEAT 10 0.0006
893 NERVOUSNESS 29 0.0006
894 RESTLESSNESS 20 0.0005
895 VIRAL INFECTION 18 0.0005
896 LIP SWELLING 18 0.0005
897 ARTHROPATHY 30 0.0005
898 MIDDLE INSOMNIA 10 0.0005
899 THERAPY NON-RESPONDER 24 0.0005
900 INFLUENZA 59 0.0005
901 DRY EYE 26 0.0005
902 ANXIETY 148 0.0005
903 EYE DISORDER 17 0.0005
904 PRESCRIBED OVERDOSE 10 0.0005
905 FEMUR FRACTURE 16 0.0005
906 DEPRESSED MOOD 27 0.0005
907 INFLUENZA LIKE ILLNESS 42 0.0005
908 COMA 24 0.0005
909 UPPER LIMB FRACTURE 10 0.0005
910 METABOLIC ACIDOSIS 16 0.0005
911 HEPATIC CANCER 12 0.0005
912 PELVIC PAIN 9 0.0005
913 PARAESTHESIA 77 0.0005
914 THROAT TIGHTNESS 13 0.0005
915 PULMONARY HYPERTENSION 10 0.0005
916 ECZEMA 25 0.0005
917 HALLUCINATION, VISUAL 10 0.0005
918 INCREASED APPETITE 9 0.0005
919 ANAPHYLACTIC REACTION 26 0.0005
920 ADVERSE DRUG REACTION 42 0.0005
921 DYSKINESIA 19 0.0005
922 ANAPHYLACTIC SHOCK 12 0.0005
923 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
924 OSTEOARTHRITIS 19 0.0004
925 BLINDNESS 18 0.0004
926 URTICARIA 74 0.0004
927 SKIN IRRITATION 20 0.0004
928 HIP FRACTURE 14 0.0004
929 NEOPLASM MALIGNANT 29 0.0004
930 ADVERSE EVENT 40 0.0004
931 CARDIOVASCULAR DISORDER 11 0.0004
932 DRUG RESISTANCE 11 0.0004
933 OSTEONECROSIS 14 0.0004
934 STAPHYLOCOCCAL INFECTION 14 0.0004
935 FEELING HOT 26 0.0004
936 DEAFNESS 11 0.0004
937 PRODUCT PRESCRIBING ERROR 10 0.0004
938 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
939 NERVOUS SYSTEM DISORDER 13 0.0004
940 ILL-DEFINED DISORDER 25 0.0004
941 DEPRESSION 93 0.0004
942 CHRONIC KIDNEY DISEASE 31 0.0004
943 BRONCHITIS 30 0.0004
944 HYPERSENSITIVITY 75 0.0004
945 DEMENTIA 11 0.0004
946 MUSCLE TWITCHING 9 0.0004
947 ANGER 13 0.0004
948 ANGIOEDEMA 17 0.0004
949 HOSPITALISATION 58 0.0004
950 HYPERHIDROSIS 48 0.0004
951 WEIGHT INCREASED 83 0.0004
952 TYPE 2 DIABETES MELLITUS 12 0.0004
953 PRODUCT DOSE OMISSION 23 0.0004
954 WHEEZING 20 0.0003
955 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
956 PROCEDURAL PAIN 9 0.0003
957 DRUG INEFFECTIVE 417 0.0003
958 DISCOMFORT 19 0.0003
959 ROAD TRAFFIC ACCIDENT 13 0.0003
960 HOT FLUSH 23 0.0003
961 TOXICITY TO VARIOUS AGENTS 48 0.0003
962 EYE PAIN 16 0.0003
963 IRRITABILITY 17 0.0003
964 ABNORMAL BEHAVIOUR 11 0.0003
965 EYE SWELLING 10 0.0003
966 FLUSHING 27 0.0003
967 TREATMENT FAILURE 22 0.0003
968 HYPOACUSIS 11 0.0003
969 MENTAL DISORDER 11 0.0003
970 INCORRECT DOSE ADMINISTERED 56 0.0002
971 AGGRESSION 12 0.0002
972 OCULAR HYPERAEMIA 11 0.0002
973 COLITIS ULCERATIVE 10 0.0002
974 SKIN BURNING SENSATION 16 0.0002
975 EXTRA DOSE ADMINISTERED 9 0.0002
976 AGITATION 16 0.0002
977 EYE IRRITATION 12 0.0002
978 PRODUCT DOSE OMISSION ISSUE 60 0.0002
979 CONDITION AGGRAVATED 61 0.0002
980 SUICIDE ATTEMPT 11 0.0002
981 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
982 SURGERY 9 0.0002
983 RHEUMATOID ARTHRITIS 16 0.0001
984 PSORIASIS 18 0.0001
985 UNEVALUABLE EVENT 10 0.0001
986 PROSTATE CANCER 10 0.0001
987 OVERDOSE 23 0.0001
988 EMOTIONAL DISTRESS 10 0.0001
989 ASTHMA 9 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
991 NO ADVERSE EVENT 10 0.0001
992 INJECTION SITE PAIN 10 0.0000